VR
Vivek Ramaswamy
10% Owner

Vivek Ramaswamy insider trades: Roivant Sciences (ROIV) stock buys and sales

10% Owner, Roivant Sciences Last trade Dec 15, 2025 20 Form 4 filings
$105.9M
Sold, last 12 months
2 sales
$0
Bought, last 12 months
0 buys
9
Open-market trades
since 2023
4
Companies
last trade 2025

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Vivek reports to the SEC

Open-market buys and sales

9 trades reported on SEC Form 4, newest first

DateStockTypeValue
Dec 15, 2025ROIV↓ Sell$67.9M
Nov 17, 2025ROIV↓ Sell$37.9M
Nov 5, 2025ASST↑ Buy$1.3M
Sep 5, 2025ROIV↓ Sell$22.5M
Jun 20, 2025ROIV↓ Sell$13.1M
Jun 6, 2025ROIV↓ Sell$8.5M
May 7, 2025ROIV↓ Sell$10.1M
Jan 2, 2024ROIV↓ Sell$33.2M
Feb 22, 2023ROIV↓ Sell$31.8M

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other ROIV insiders

Open-market trades in the last 12 months

About Vivek Ramaswamy's insider trades

Vivek Ramaswamy is a 10% owner of Roivant Sciences (ROIV). Since Feb 22, 2023, Vivek has reported 1 open-market purchase worth $1.3M and 8 sales worth $225.0M on SEC Form 4. In the last 12 months: 2 sales ($105.9M).

Their filings also include option exercises (6 filings), other transactions (5 filings), grants and awards (5 filings), gifts (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ROIV insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.